Replies to post #195 on Idenix Pharmaceuticals (IDIX)

[DewDiligence]

CFO resigns. Coming on the heels on the
departure of the CMO two months ago,
this is definitely not good.

http://biz.yahoo.com/prnews/070320/cltu204.html?.v=5

>>
Idenix Pharmaceuticals, Inc. Announces Resignation of Chief Financial Officer

Tuesday March 20, 4:05 pm ET

CAMBRIDGE, Mass., March 20 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX ) today announced that David Arkowitz, chief financial officer and treasurer, has resigned effective March 30, 2007 to pursue an opportunity at another life sciences company. David Blanchard, Idenix's vice president of finance, who has been with Idenix since 2000, will serve as interim chief financial officer with responsibility for finance and information technology until a national search for a new chief financial officer is complete.

"Over the past three years, David has played an integral role in the establishment of the essential infrastructure and key governance and business processes to support Idenix's growth as a public company and the commercialization of our first product," said Jean-Pierre Sommadossi, chief executive officer and chairman of Idenix. "We are thankful for his contributions and wish him success in his new endeavor."
<<